EUVIMEDEUVIMED entdecken
Open Access

Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling

Chang-Lun Huang, David Achudhan, Po-I Liu, Yen-You Lin, Shan-Chi Liu, Jeng-Hung Guo, Chun-Lin Liu, Chih-Ying Wu, Shih-Wei Wang, Chih-Hsin Tang

Aging · 2023

DOI: 10.18632/aging.204762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Chang-Lun Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Science, College of Medicine, China Medical University, Taichung 40402, Taiwan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymph node metastasis is a recognized prognostic factor in esophageal cancer. Adipokines, including visfatin, and the molecule vascular endothelial growth factor (VEGF)-C, are implicated in lymphangiogenesis, but whether any association exists between esophageal cancer, adipokines and VEGF-C is unknown. We examined the relevance of adipokines and VEGF-C in esophageal squamous cell carcinoma (ESCC) in the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. We found significantly higher levels of visfatin and VEGF-C expression in esophageal cancer tissue than in normal tissue. Immunohistochemistry (IHC) staining identified that higher levels of visfatin and VEGF-C expression were correlated with advanced stage ESCC. Visfatin treatment of ESCC cell lines upregulated VEGF-C expression and VEGF-C-dependent lymphangiogenesis in lymphatic endothelial cells. Visfatin induced increases in VEGF-C expression by activating the mitogen-activated protein kinase kinases1/2-extracellular signal-regulated kinase (MEK1/2-ERK) and Nuclear Factor Kappa B (NF-κB) signaling cascades. Transfecting ESCC cells with MEK1/2-ERK and NF-κB inhibitors (PD98059, FR180204, PDTC, and TPCK) and siRNAs inhibited visfatin-induced increases in VEGF-C expression. It appears that visfatin and VEGF-C are promising therapeutic targets in the inhibition of lymphangiogenesis in esophageal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansNF-kappa BLymphangiogenesisVascular Endothelial Growth Factor CEndothelial CellsNicotinamide PhosphoribosyltransferaseVascular Endothelial Growth Factor AAdipokines

Stichwörter der Autor:innen

VEGF-Ccanceresophageallymphangiogenesisvisfatin

Substanzen

NF-kappa BVascular Endothelial Growth Factor CNicotinamide PhosphoribosyltransferaseVascular Endothelial Growth Factor AAdipokines

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Science, College of Medicine, China Medical University, Taichung 40402, Taiwan.
  • Department of Surgery, Division of Thoracic Surgery, Changhua Christian Hospital, Changhua 500, Taiwan.
  • Department of General Thoracic Surgery, Asia University Hospital, Taichung 41354, Taiwan.
  • Department of Physical Therapy, Asia University, Taichung 41354, Taiwan.
  • Department of Pharmacology, School of Medicine, China Medical University, Taichung 40402, Taiwan.
  • Department of Medical Education and Research, China Medical University Beigang Hospital, Yunlin 65152, Taiwan.

Zitieren

APA

Huang, C. L., Achudhan, D., Liu, P. I., Lin, Y. Y., Liu, S. C., Guo, J. H., Liu, C. L., Wu, C. Y., Wang, S. W., & Tang, C. H. (2023). Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling. Aging. https://doi.org/10.18632/aging.204762

Vancouver

Huang CL, Achudhan D, Liu PI, Lin YY, Liu SC, Guo JH, et al. Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling. Aging. 2023. doi:10.18632/aging.204762

BibTeX
@article{Huang2023,
  author = {Huang, Chang-Lun and Achudhan, David and Liu, Po-I and Lin, Yen-You and Liu, Shan-Chi and Guo, Jeng-Hung and Liu, Chun-Lin and Wu, Chih-Ying and Wang, Shih-Wei and Tang, Chih-Hsin},
  title = {Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204762}
}
Kostenlos starten →